ICU immune cell study halted: what it could have revealed

NCT ID NCT06415474

Terminated Knowledge-focused Sponsor: University Hospital, Brest Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times

Summary

This study aimed to track how different immune cells (lymphocytes) change over time in ICU patients with severe infections or injuries. Researchers hoped to better understand 'immunoparalysis,' a state where the immune system becomes weak after severe inflammation. The study was terminated after enrolling 38 participants, so results are limited.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PATIENTS UNDERGOING ESOPHAGECTOMY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PATIENTS UNDERGOING ESOPHAGECTOMY PATIENTS WITH ABDOMINAL INFECTION PATIENTS WITH SEVERE NEUROLOGICAL LESION PATIENTS WITH SEVERE POLYTRAUMA

Contacts and locations

Locations

CHU de Brest

Brest, 29609, France